Vendor:Al Faris National Company for Investment and Export PSC
From LIMSWiki
Jump to navigationJump to searchThe printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
| Type | Professional corporation |
|---|---|
| Industry |
Business intelligence Laboratory informatics |
| Headquarters | Mecca Street, Mecca Towers, Complex No.172, 1st Floor, Amman, Jordan |
| Area served | Middle East and Asia |
| Products |
Products list
|
| Website | optimiza.me |
| https://www.linkedin.com/company/optimiza/ |
Al Faris National Company for Investment and Export PSC—doing business as OPTIMIZA—develops and distributes business intelligence and laboratory informatics software solutions.
History
The company was founded in 1983.[1]
Technology and products
AccuLab and AccuLink
AccuLab LIS is a cloud-based laboratory information system (LIS) solution that "not only enhances services and expands the customer base but also boosts revenue and effectively reduces overall costs."[2] The software can be deployed locally or in the cloud.[2]
Acculink is a cloud-based middleware solution that "offers higher levels of integration with laboratory analyzers and 3rd party systems."[3]
Pricing
Pricing information not made public.
Demonstration videos and other media
The following demo videos exist for AccuLab:
Additional information
References
- ↑ "Al Faris National Investment Group (Optimiza)". Who's Who in Jordan's Information and Communication Technology. MediaScope Ltd. 2019. http://www.jordanict.com/company-profile/al-faris-national-investment-group-optimiza. Retrieved 28 September 2019.
- ↑ 2.0 2.1 "AccuLab Laboratory Information System". Al Faris National Company for Investment and Export PSC. https://optimiza.me/index.php/acculab-product/. Retrieved 06 December 2023.
- ↑ "AccuLink Laboratory Middleware". Al Faris National Company for Investment and Export PSC. https://optimiza.me/index.php/product/acculink/. Retrieved 06 December 2023.
